Icon
+91 94997 68112
Login Register

Corlanor - (5, 7.5 mg; Tablet, Oral)

Ivabradine Amgen
5, 7.5 mg; Tablet, Oral
Less Than $1000 mn
More Than 5
More Than 5
More Than 5
Less Than 5
Less Than 5
 None
Corlanor is indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate
Yes
*** *********** ******* **- *** **, ****. ******** ****** ** ********** ***** ** *** ****. *******, ***** ******. **** ******, ****** ******, ******* ******, *** **** *** ****. **** ***** * **** ** ** *** ******* *** **** *********. ** ****** **** **** **** ****** ** **** ****. *****, ******* ***** * **** ** *** *** *********. ***** ** **** **, **** ******* **** **** ** **. ********** ******* **** **** ******
Corlanor Patent 1 Patent 2 Patent 3 Patent 4
******* ******* ******* ******* *******
***** ****** **** ** ** **** ** ** **** ** ** **** ** **
**** ****** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ********* ***** **, **** ******* **** ** *** **, ****
***** ****** *** \ ** ***** **, **** **** ** ** ******** ***** ***-**** ***********
**** ****** *** \ ********* ***** **, **** ******* **** ** *** **, ****
  1. *** *, **** : ******* ******** ***** ***** **'* **** ** ****** ** *** *******.
  2. *** *, **** : ***** ****** ******** ***** ***** **'* **** ** ****** ** *** *******.
  3. *** **, **** : **** ****** *** ****** ****** (******) ******** ***** ***** **'* **** ** ****** ** *** *******.
  4. *** **, **** : ******* ****** ******** ***** ***** **'* **** ** ****** ** *** *******.
  5. *** **, **** : *** **** ******** ***** ***** **'* **** ** ****** ** *** *******.
  6. *** **, **** : ***** ***** * **** ******* ******* ** *** *******.
  7. *** **, **** : ***** ***** * **** ******* ***** ****** ** *** *******.
  8. *** **, **** : ***** ***** * **** ******* **** ****** ** *** *******.
  9. *** **, **** : ***** ***** * **** ******* ****** ****** *** ******* ****** ** *** *******.
  10. *** **, **** : ***** ***** * **** ******* *** **** ** *** *******.
  11. *** *, **** : ******* ******** ***** ***** **'* **** ** ****** ** *** *******.
  12. *** **, **** : ***** ***** * **** ******* ******* ** *** ******* '*** '*** '*** *** '***.
  13. *** **, **** : ******* ****** **** ** ******* '*** '*** '*** *** '*** ** **
  14. *** *, **** : ******* **** ** ** *** ***** ******* *****.
  15. *** **, **** : ***** ******* **** *** **** ***** ******* *****.
  16. *** *, **** : ***** ******* **** **** ****** ** ******* ***** ** **********.
  17. *** **, **** : ***** **** ********** ** *** ******* ** **
  18. *** *, **** : ****** **** ** ** ** *** *******.
  19. *** **, **** : ***** ******* **** ******* ***** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.